Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Get Started with GLP-1s Your weight loss journey should fit you
Medi-Cal will continue to cover GLP-1s when used for FDA-approved, non-weight-loss indications (e.g., type 2 diabetes, ASCVD, CKD) with appropriate ICD-10 codes and, when required, prior authorization
Depends on the site for injection
Interferential Current (IFC) Therapy IFC therapy is a non-invasive treatment that uses gentle electrical currents to reduce pain, improve circulation, and accelerate healing
With the approval of the first oral GLP-1 and the potential for new indications, such as the treatment of Alzheimers disease, sleep apnea and certain types of cancers, the weight loss medication landscape will continue to move fast
